BioSpace News Archive

Drug Development

TesoRx Announces Commencement of Enrollment of a Clinical Trial Evaluating Novel Oral Testosterone Replacement Therapy in Patients with Hypogonadism

Results from the study are expected to validate dose response pharmacokinetics of TSX-011 along with safety and tolerability.

November 30, 2017

·

2 min read

Business

Takeda Appoints Toshio Fujimoto, MD, MBA, as General Manager of the Health Innovation Park in Shonan

The appointment is effective as of December 1, 2017.

November 30, 2017

·

6 min read

Biotech Beach

TearLab Launches Registered Direct Offering

The Company plans to use the proceeds of this offering for general corporate purposes.

November 30, 2017

·

4 min read

Drug Development

BeyondSpring Initiates Global Phase II/III Trial With Plinabulin in China for the Prevention of Chemotherapy-Induced Neutropenia to Demonstrate Superiority

The initiation took place on Nov. 29, 2017, at the Harbin Medical University Cancer Hospital in Harbin, China, led by Co-Principal Investigator Dr. Qingyuan Zhang.

November 30, 2017

·

5 min read

Drug Development

RespireRx Pharmaceuticals Announces Publication of Phase IIB PACE Study: Once per Night Treatment with Dronabinol Provides Statistically Significant Improvement in Clinical Measures of Obstructive Sleep Apnea

The PACE paper is published in the journal SLEEP, the official publication of the Sleep Research Society, and the leading peer-reviewed journal in sleep and circadian science.

November 30, 2017

·

10 min read

Drug Development

Novartis’ Cosentyx is First Biologic to Show Long-Term Efficacy in Nail and Palmoplantar Psoriasis, Which Can Impact Up to 90% of Psoriasis Patients

These new data from a clinical study were presented at the 8th International Congress of Psoriasis from Gene to Clinic in London, UK.

November 30, 2017

·

15 min read

Drug Development

TRACON Doses First Patient in Phase Ib Study of TRC105 With Opdivo in Patients With Lung Cancer

The Phase 1b clinical trial is an open-label, dose-escalation and expansion cohort study of TRC105 and Opdivo in patients with non-small cell lung cancer that have received prior chemotherapy.

November 30, 2017

·

3 min read

FDA

Amphastar Announces Approval for Medroxyprogesterone Acetate Injectable Suspension, USP

Amphastar’s newly approved products were determined by the FDA to be therapeutically equivalent to Depo-Provera Contraceptive Injection sold in the United States by Pfizer.

November 30, 2017

·

3 min read

Business

Cook Group Expands My Cook Pathway Program with New IWU Tuition Discount

Cook Group announced a new partnership with Indiana Wesleyan University.

November 30, 2017

·

2 min read

Deals

Corazon and NanoSphere Announce Completion of $5.9M Financing and Merger

Based upon the CSE’s conditional listing approval, the Company will make its final submission for CSE listing in short order, and concurrently with its listing on the CSE will change its name to “NanoSphere Health Sciences Inc.” and effect a de-listing from the TSX Venture Exchange.

November 30, 2017

·

6 min read